Articles

Feline Infectious Peritonitis (FIP) is a serious and often fatal disease caused by a mutation of the feline coronavirus. It predominantly affects young cats, especially those under two years old, and cats in crowded environments like shelters or breeding facilities. FIP manifests in two main forms:

1. Wet FIP (Effusive): Characterized by fluid accumulation in the abdomen or chest, leading to swelling and difficulty breathing. Symptoms include lethargy, weight loss, and fever.

2. Dry FIP (Non-Effusive): This form doesn’t involve fluid buildup but causes granulomas in organs, leading to neurological problems, liver issues, and eye inflammation.

Diagnosis can be challenging, as symptoms overlap with other diseases. A combination of blood tests, imaging, and fluid analysis (for wet FIP) helps confirm the diagnosis.

Treatment options for FIP have dramatically improved with the advent of GS-441524, an antiviral medication that has shown promise in bringing cats into remission, especially if administered early.

Prevention is difficult due to the widespread nature of the virus, but minimizing stress, maintaining hygiene, and supporting a cat's immune system can help reduce the risk.

For more information, visit FIPcureplus.com.

We are pleased to inform our clients that our GS-441524 formulations, including concentrations of 20mg/ml and 30mg/ml, have passed rigorous testing by independent laboratories. We guarantee that each batch of medication meets or exceeds the concentration levels specified on our website. If any batch fails to meet these standards, it is returned to the manufacturer for immediate reformulation to ensure quality control.

By adhering to the dosage guidelines provided by our dosage calculator, you can confidently administer the correct amount of GS-441524 to your cat for effective treatment of Feline Infectious Peritonitis (FIP). Our commitment to quality and precision ensures your cat receives the best care possible during their treatment.

For severe cases of FIP, administering two injections per day—each at 50% of the daily dosage, spaced 12 hours apart—ensures optimal treatment. The antiviral medication GS-441524 has a half-life of approximately 3-4 hours, meaning its concentration in the bloodstream decreases steadily after each injection. By splitting the dose into two injections, you can maintain higher levels of GS-441524, improving the drug's ability to suppress the FIP virus more effectively.

For instance, if a 4kg cat with Dry FIP requires 1.88ml of GS-441524 per day, the first injection would deliver 18.8mg, and the second injection would help maintain its concentration, preventing it from dropping too low and allowing for more consistent viral suppression throughout the day.

Key Benefits include:

• Higher GS-441524 levels for more effective viral suppression.
• Reduced injection pain, as splitting the dose into smaller amounts minimizes discomfort, especially in larger cats requiring higher dosages.

While a single injection per day is effective, splitting the dosage helps enhance both efficacy and comfort for your cat.

For further details, visit FIPcureplus.com.

At FIPcureplus, we introduced our new 20mg/ml and 30mg/ml GS-441524 formulations to address several key challenges in treating FIP. One of the main reasons for these higher concentrations is to prevent under-dosage deaths, particularly in non-effusive dry FIP cases, where the virus's severity can be difficult to assess. These higher doses help reduce relapses, which are often caused by prolonged under-dosing, and ensure that more severe cases, such as neurological FIP, receive the necessary strength of treatment.

Additionally, these formulations are designed to reduce the pain and stress associated with injections for larger cats and make FIP treatment more affordable for owners. Early testing on 12 cats across 6 countries has shown promising results, with most cats showing significant improvements. These new formulations not only help cats recover but also provide a more efficient, comfortable, and cost-effective solution for managing FIP.

For more information, visit FIPcureplus